April 11 2019 – World Parkinson’s Awareness Day

April 11, 2019 is World Parkinson’s Awareness Day and we are commemorating this day by offering a 20% discount voucher off all Parkinson’s reports. Apply parkinsons20 at checkout to gain a 20% discount.

Access reports that include a disease overview, market forecast, treatment, and future trends for this chronic and progressive neurodegenerative disorder, characterized by tremors, rigidity, bradykinesia (slowness of movement), and postural instability.

Related Reports

Parkinson's Disease

Parkinson’s disease is a chronic and progressive neurodegenerative disorder characterized by tremors, rigidity, bradykinesia (slowness of movement), and postural instability. Patients also experience significant non-motor symptoms including changes in cognition and mood, sleep disturbances, and autonomic dysfunction. The condition is caused by the degeneration of dopamine-producing cells of the substantia nigra. Parkinson’s disease is incurable, but non-fatal, resulting in poor quality of life and increasing disability as the disease progresses.

Parkinson's Disease

Datamonitor Healthcare interviewed two neurologists, one based in Italy and the other in the US, to gauge their prescribing habits and views on current treatment options and challenges, late-stage clinical candidates and pricing and reimbursement considerations for Parkinson’s disease. The drugs discussed are listed below. The two interviews were combined into a single report.